Literature DB >> 1389949

N-demethylation of ethylmorphine in pregnant and non-pregnant women and in men: an evaluation of the effects of sex steroids.

E Gerdin1, A Rane.   

Abstract

1. The effects of oestrogens, testosterone, progesterone and medroxyprogesterone acetate (MPA) on the rate of N-demethylation of ethylmorphine (EM) to norethylmorphine (NEM) were studied in human adult liver microsomes. 2. N-Demethylase activity was found to be inhibited by progesterone and MPA to a similar extent while oestrogens and testosterone had no or negligible effects. 3. These findings prompted us to measure the N-demethylation of EM in relation to serum progesterone concentration in vivo in three groups of volunteers with large physiological differences in their endogenous levels of progesterone, i.e. i) pregnant women, ii) non-pregnant ovulating women and iii) men. 4. The metabolic ratio (MRP) of EM to NEM in plasma 60 min after dosage and the corresponding ratio in urine sampled for 6 h (MRU,1), measured on two occasions 14 days apart were used to reflect intraindividual variation in the rate of N-demethylation. 5. The average difference in MRP and MRU,1 between the two occasions was similar in all groups. However, the variability in MRP between individuals within a group was significantly higher in ovulating women than in men, but this had no relation to the serum concentrations of progesterone or oestradiol. 6. The cumulative 12 h urinary excretion of EM, NEM and morphine (MO) after hydrolysis with beta-glucuronidase was about 46%. There was no difference in the metabolic ratio of EM to NEM and its conjugate(s) in the urine between the luteal and the follicular phases. Our findings suggest that the menstrual cycle does not influence the rate of N-demethylation of EM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1389949      PMCID: PMC1381396          DOI: 10.1111/j.1365-2125.1992.tb04132.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Metabolic N- and O-demethylation of morphine- and morphinan-type analgesics.

Authors:  A E TAKEMORI; G J MANNERING
Journal:  J Pharmacol Exp Ther       Date:  1958-07       Impact factor: 4.030

Review 2.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci.

Authors:  D W Nebert; D R Nelson; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper
Journal:  DNA       Date:  1989 Jan-Feb

Review 3.  Characterization of human microsomal cytochrome P-450 enzymes.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

4.  Human fetal and adult liver metabolism of ethylmorphine. Relation to immunodetected cytochrome P-450 PCN and interactions with important fetal corticosteroids.

Authors:  M G Ladona; D J Spalding; L Ekman; B Linström; A Rane
Journal:  Biochem Pharmacol       Date:  1989-10-01       Impact factor: 5.858

5.  The additive effects of progestins on testosterone-stimulated hepatic ethylmorphine metabolism and cytochrome P-450 content.

Authors:  T R Brown; F E Greene; C W Bardin
Journal:  Steroids       Date:  1977-12       Impact factor: 2.668

6.  Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes.

Authors:  D J Waxman; G A Dannan; F P Guengerich
Journal:  Biochemistry       Date:  1985-07-30       Impact factor: 3.162

7.  Induction of monooxygenases and growth in rat liver by progesterone.

Authors:  H Ochs; B Düsterberg; R Schulte-Hermann
Journal:  Arch Toxicol       Date:  1986-10       Impact factor: 5.153

8.  Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism.

Authors:  F P Guengerich; M V Martin; P H Beaune; P Kremers; T Wolff; D J Waxman
Journal:  J Biol Chem       Date:  1986-04-15       Impact factor: 5.157

9.  Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes.

Authors:  S E Ball; L M Forrester; C R Wolf; D J Back
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  3 in total

Review 1.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 2.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

3.  Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose.

Authors:  T A Aasmundstad; B Q Xu; I Johansson; A Ripel; A Bjørneboe; A S Christophersen; E Bodd; J Mørland
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.